{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T04:05:20Z","timestamp":1793505920361,"version":"4.5.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1007\/s00415-009-5275-3","type":"journal-article","created":{"date-parts":[[2009,7,31]],"date-time":"2009-07-31T13:39:43Z","timestamp":1249047583000},"page":"91-97","source":"Crossref","is-referenced-by-count":215,"title":["Enzyme replacement therapy with alglucosidase alfa in 44 patients with late-onset glycogen storage disease type 2: 12-month results of an observational clinical trial"],"prefix":"10.1007","volume":"257","author":[{"given":"S.","family":"Strothotte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Strigl-Pill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Grunert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Kornblum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Eger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Wessig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Deschauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Breunig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. X.","family":"Glocker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Vielhaber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Brejova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Hilz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Reiners","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"M\u00fcller-Felber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Mengel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Spranger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedikt","family":"Schoser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,8,1]]},"reference":[{"key":"5275_CR1","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/S0140-6736(08)61555-X","volume":"372","author":"AT Ploeg Van der","year":"2008","unstructured":"Van der Ploeg AT, Reuser AJJ (2008) Lysosomal storage disease 2\u2013Pompe\u2032s disease. Lancet 372:1342\u20131352","journal-title":"Lancet"},{"key":"5275_CR2","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ymgme.2008.09.001","volume":"95","author":"LE Case","year":"2008","unstructured":"Case LE, Koeberl DD, Young SP, Bali D, De Armey SM, Mackey J, Kishnani PS (2008) Improvement with ongoing enzyme replacement therapy in advanced late-onset Pompe disease: a case study. Mol Genet Metab 95:233\u2013235","journal-title":"Mol Genet Metab"},{"key":"5275_CR3","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/nrm1050","volume":"4","author":"P Ghosh","year":"2003","unstructured":"Ghosh P, Dahms NM, Kornfeld S (2003) Mannose 6-phosphate receptors: new twists in the tale. Nat Rev Mol Cell Biol 4:202\u2013212","journal-title":"Nat Rev Mol Cell Biol"},{"key":"5275_CR4","unstructured":"Joshi PR, Glaeser D, Schmidt S, Vorgerd M, Winterholler M, Eger K, Zierz S, Deschauer M Molecular genetic characterization of German patients with late-onset glycogen storage disease type II. J Inherit Metab Dis, PMID: 18607768 (in press)"},{"key":"5275_CR5","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.jpeds.2005.11.033","volume":"148","author":"PS Kishnani","year":"2006","unstructured":"Kishnani PS, Hwu WL, Mandel H, Nicolino M, Yong F, Corzo D (2006) A retrospective, multinational, multicenter study on the natural history of infantile-onset Pompe disease. J Pediatr 148:671\u2013676","journal-title":"J Pediatr"},{"key":"5275_CR6","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1146\/annurev.bi.61.070192.001515","volume":"61","author":"S Kornfeld","year":"1992","unstructured":"Kornfeld S (1992) Structure and function of the mannose 6-phosphate\/insulinlike growth factor II receptors. Annu Rev Biochem 61:307\u2013330","journal-title":"Annu Rev Biochem"},{"key":"5275_CR7","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/(SICI)1096-8628(19980827)79:1<69::AID-AJMG16>3.0.CO;2-K","volume":"79","author":"F Martiniuk","year":"1998","unstructured":"Martiniuk F, Chen A, Mack A, Arvanitopoulos E, Chen Y, Rom WN et al (1998) Carrier frequency for glycogen storage disease type II in New York and estimates of affected individuals born with the disease. Am J Med Genet 79:69\u201372","journal-title":"Am J Med Genet"},{"key":"5275_CR8","doi-asserted-by":"crossref","first-page":"6780","DOI":"10.1074\/jbc.M404008200","volume":"280","author":"RJ Moreland","year":"2005","unstructured":"Moreland RJ, Jin X, Zhang XK, Decker RW, Albee KL, Lee KL et al (2005) Lysosomal acid alpha-glucosidase consists of four different peptides processed from a single chain precursor. J Biol Chem 280:6780\u20136791","journal-title":"J Biol Chem"},{"key":"5275_CR9","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.nmd.2007.06.002","volume":"17","author":"W M\u00fcller-Felber","year":"2007","unstructured":"M\u00fcller-Felber W, Horvath R, Gempel K, Podskarbi T, Shin YS, Pongratz D, Walter MC, Baethmann M, Schlotter-Weigel B, Lochm\u00fcller H, Schoser BGH (2007) Late-onset Pompe disease: clinical and neurophysiological spectrum of 38 patients with a long-term follow-up in 18 patients. Neuromuscul Disord 17:698\u2013706","journal-title":"Neuromuscul Disord"},{"key":"5275_CR10","first-page":"304","volume":"76","author":"JC Pompe","year":"1932","unstructured":"Pompe JC (1932) Over idiopathische hypertrofie van het hart. Ned Tijdsch Geneesk 76:304\u2013311","journal-title":"Ned Tijdsch Geneesk"},{"key":"5275_CR11","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1177\/0883073807302598","volume":"22","author":"M Rossi","year":"2007","unstructured":"Rossi M, Parenti G, Della CR, Romano A, Mansi G, Agovino T et al (2007) Long-term enzyme replacement therapy for Pompe disease with recombinant human alphaglucosidase derived from Chinese hamster ovary cells. J Child Neurol 22:565\u2013573","journal-title":"J Child Neurol"},{"key":"5275_CR12","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/j.1365-2990.2007.00839.x","volume":"33","author":"BGH Schoser","year":"2007","unstructured":"Schoser BGH, M\u00fcller-H\u00f6cker J, Gempel K, Horvath R, Pongratz D, Lochm\u00fcller H, Muller-Felber W (2007) Glycogen storage disease type 2: clinic-pathological phenotype revisited. Neuropathol Appl Neurol 33:544\u2013559","journal-title":"Neuropathol Appl Neurol"},{"key":"5275_CR13","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.nurt.2008.08.009","volume":"5","author":"B Schoser","year":"2008","unstructured":"Schoser B, Hill V, Raben N (2008) Therapeutic approaches in glycogen storage disease type II (GSDII)\/Pompe disease. Neurotherapeutics 5:569\u2013578","journal-title":"Neurotherapeutics"},{"key":"5275_CR14","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.nmd.2008.11.007","volume":"19","author":"NAME Beek Van der","year":"2009","unstructured":"Van der Beek NAME, Hagemans MLC, Reuser AJJ, Hop WCJ, Van der Ploeg AT, Van Doorn PA, Wokke JHJ (2009) Rate of disease progression during long-term follow-up of patients with late-onset Pompe disease. Neuromuscul Disord 19:113\u2013117","journal-title":"Neuromuscul Disord"},{"key":"5275_CR15","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/ana.20019","volume":"55","author":"LP Winkel","year":"2004","unstructured":"Winkel LP, Van den Hout JM, Kamphoven JH, Disseldorp JA, Remmerswaal M, Arts WF et al (2004) Enzyme replacement therapy in late-onset Pompe\u2019s disease: a three-year follow-up. Ann Neurol 55:495\u2013502","journal-title":"Ann Neurol"},{"key":"5275_CR16","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s00415-005-0922-9","volume":"252","author":"LP Winkel","year":"2005","unstructured":"Winkel LP, Hagemans ML, Van Doorn PA, Loonen MC, Hop WJ, Reuser AJ et al (2005) The natural course of non-classic Pompe\u2019s disease; a review of 225 published cases. J Neurol 252:875\u2013884","journal-title":"J Neurol"},{"key":"5275_CR17","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1016\/S0021-9258(18)53985-5","volume":"268","author":"HA Wisselaar","year":"1993","unstructured":"Wisselaar HA, Kroos MA, Hermans MM, van Beeumen J, Reuser AJ (1993) Structural and functional changes of lysosomal acid alpha-glucosidase during intracellular transport and maturation. J Biol Chem 268:2223\u20132231","journal-title":"J Biol Chem"},{"key":"5275_CR18","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1002\/mus.21025","volume":"35","author":"JHJ Wokke","year":"2008","unstructured":"Wokke JHJ, Escolar DM, Pestronk A, Jaffe KM, Carter GY, van den Berg LH, Florence JM, Mayhew J, Skrinar A, Corzo D, Laforet P (2008) Clinical features of late-onset Pompe disease: a prospective cohort study. Muscle Nerve 35:1236\u20131245","journal-title":"Muscle Nerve"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-009-5275-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-009-5275-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-009-5275-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T16:16:24Z","timestamp":1710519384000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-009-5275-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8,1]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["5275"],"URL":"https:\/\/doi.org\/10.1007\/s00415-009-5275-3","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,8,1]]}}}